We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Panel Splits on Integra LifeSciences' SurgiMend for Breast Reconstruction
FDA Advisory Panel Splits on Integra LifeSciences' SurgiMend for Breast Reconstruction
The FDA usually follows the advice of its advisory committees, but what that will mean in the case of Integra LifeSciences' SurgiMend for breast reconstruction is anybody’s guess, because the agency’s General and Plastic Surgery Devices Panel was deeply divided on the device’s safety and efficacy when it met last week.